Book Navigation

We are sorry, but signing in with LinkedIn is not possible at this time.



This GIN award acknowledges an individual’s contribution to innovation in the methodology, development, and /or implementation of clinical practice guidelines.

Najoua Mlika-Cabanne October 2008

Najoua Mlika-Cabanne


The Najoua Mlika-Cabanne Innovation Award is named in memory of Najoua Mlika-Cabanne MD PHD, formerly Deputy Head of the Guidelines Department at the Haute Autorité de Santé (HAS, French National Authority for Health), Trustee of the Guidelines International Network between 2003 and 2010, and GIN Honorary Patron

Najoua Mlika-Cabanne graduated in medicine from Sousse Medical Faculty in Tunisia in 1982. From a local government post in public health in Tunisia, Najoua moved to clinical research in France first at the Gustave Roussy Cancer Centre and then at INSERM, the French National Institute for Health and Medical Research. After that Najoua became deputy head of the Guidelines Department at the Haute Autorité de Santé (HAS, French National Authority for Health). She was in charge of various aspects of the development of clinical practice guidelines for over 10 years: drafting of guidelines, managing a team of guideline developers, and university teaching, in particular courses on medical statistics, quality management, and assessment of health systems. In her post at HAS, she liaised with experts in a very wide variety of aspects of the development of quality of care and health technology assessment.

From 2000, Najoua was increasingly involved in national and international partnerships. She was on the Committee for the Assessment of National Registers at the French Institute for Public Health Surveillance (InVS), was the mandated HAS representative for several collaborative international projects (for example, CoCanCPG), and was an active member of the International Review Panel of the International Society for Quality in Healthcare (ISQUA), the ADAPTE collaboration, and GIN.

Najoua was elected to the GIN Board in 2003 and was co-chair of the international Working Group on Evidence Tables. She was also a co-editor of enGINe, the GIN newsletter.

During her career Dr Najoua Mlika-Cabanne made a significant contribution to the science of clinical guideline development and consistently fostered international collaboration and friendship.   


Previous Award Recipients

Seventh award 2019 - David Phillippo

David Phillippo






Sixth award 2018 - Robin Vernooij

Robin Vernooij






Fifth award 2017 - Dr Linn Brandt

Linn Brandt2









Fourth award 2016 - Richard Rosenfeld and Ilkka Kunnamo













Third Award 2015 - Philip van der Wees

 Philip van der Wees



Second award 2014 - Jeremy Grimshaw

Jeremy Grimshaw



 First award 2012 - Marcia Kelson

  Marcia Kelson and NMC Award



Hector NMC 2020Hector Pardo Hernandez - 2020 Award Recipient


We are delighted to announce Dr Hector Pardo-Hernandez as the 2020 Guidelines International Network (GIN) recipient of the Najoua Mlika-Cabanne Innovation Award. Hector is currently a consultant at the WHO Regional Office for Europe and a Methods Editor for the Cochrane Common Mental Health Disorders group at the University of York (York, UK). He was formerly a Researcher at the Iberoamerican Cochrane Centre.

Hector has worked in the advancement of the clinical guideline (CG) updating enterprise, specifically in the development of a tool for prioritising clinical questions for updating within a CG. This tool, endorsed by the GIN Board in December 2019, consists of six items scored using a 7- point Likert scale: 1) impact of outdated recommendations on safety, 2) availability of new relevant evidence, 3) context relevance of the clinical question, 4) methodological applicability of the clinical question, 5) user’s interest, and 6) impact on access to health care. It also includes detailed guidance for passing the tool, rating priority items, calculating and ranking priority scores, and summarising results. The tool is pragmatic and can be adapted to meet the specific needs of different clinical guideline developing organisations. The development of the UpPriority Tool consisted of a multistep process and was based on a systematic review of prioritisation strategies for CG, systematic review and health technology assessment updating.

As Vice-Chair of the GIN Updating Guidelines Working Group, Hector has also coordinated the development of other projects related to the CG updating enterprise, including a glossary of terms related to CG updating and continuous literature surveillance for CG updating. He is also a member of the Living Evidence Network Steering Group and is currently involved in a systematic review of methods of conduct and reporting of living systematic reviews.


Besides these activities, Hector has actively researched a broad spectrum of strategies for eliciting, assessing, and incorporating patients' values and preferences in systematic reviews and CG development and updating. As such, Hector participated in the development of a search strategy for retrieving scientific literature on patients' values and preferences. This strategy has then been used in secondary research projects, including systematic reviews on how patients value prostate and breast cancer screening, COPD outcomes and self-management interventions, all of which Hector has co-authored. In addition, he has participated in systematic reviews examining approaches for incorporating patients' values and preferences during CG development, and has collaborated in the development of GRADE guidance for determining the certainty of patients' values and preferences evidence. He also participates in European-level initiatives for, among others, developing core outcome sets for different chronic conditions. Hector also plays a prominent role in the activities of the GRADE Outcome Importance Group.


Hector is currently a Consultant at the WHO Regional Office for Europe. He is working on an evidence-based assessment of the integrated delivery of health and social services for long-term care in different European countries. In this capacity, he has developed a framework and protocol for completing these assessments and has completed six of such assessments, one of which is already published.

Hector has achieved great academic success, defending his PhD thesis on Methodology of Biomedical Research and Public Health in December 2017 and obtaining the highest honours awarded by the Autonomous University of Barcelona (Cum Laude). He received similar recognitions for his Bachelor’s and MPH degrees, both obtained in the USA. He has (co-)authored over 45 scientific articles in the past few years, which have been cited over 250 times thus far.


In spite of his achievements, Hector is still in the early stages of his career. He started working in the CG field in 2016, alongside Dr Pablo Alonso-Coello, at the Iberoamerican Cochrane Centre. He was also a member of the 2018 Conference Scientific Committee in Manchester. 

February 2021
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
Page last updated: Sep 30, 2020
Back to top